UpdatesPress Release
Anupam Rasayan Q1FY27 consolidated revenue grew 36% YoY to Rs 667.5 Cr, with EBITDA up 35% to Rs 174.9 Cr.
Anupam Rasayan India LimitedANURAS · Filed with the exchange
PAT rose 6% to Rs 51.2 Cr.
Achieved ETFA commercialization milestone.
Signed US$300 million LoI with BASQUEVOLT.
Bliss GVS Pharma acquisition progressing.
No comments yet. Be the first.